4.5 Article

Soluble Amyloid-β Levels and Late-Life Depression

Journal

CURRENT PHARMACEUTICAL DESIGN
Volume 20, Issue 15, Pages 2547-2554

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/13816128113199990502

Keywords

Late-life depression; A beta 42; amyloid; plasma; cerebrospinal fluid; Alzheimer's disease; biomarkers; elderly; dementia; ApoE4

Funding

  1. 2012 NYU COE Seed Grant [NIRG 11-205479]
  2. NYU ADC Pilot Study Grants
  3. NIH [R01 AG13616, R01 AG022374, R01 AG12101, R01 MH-080405]

Ask authors/readers for more resources

Late-Life Major Depression (LLMD) is a complex heterogeneous disorder that has multiple pathophysiological mechanisms such as medical comorbidity, vascular-related factors and Alzheimer's disease ( AD). There is an association between LLMD and AD, with LLMD possibly being a risk factor for, or early symptom of AD and vascular dementia. Whether depression is an etiologic risk factor for dementia, or part of the dementia prodrome remains controversial. AD has a long prodromal period with the neuropathologic features of the disease preceding the onset of clinical symptoms by as much as 15-20 years. Clinicopathological studies have provided robust support for the importance of A beta 42 in the pathogenesis of AD, but several other risk factors have also been identified. Given the relationship between A beta 42 and AD, a potential relationship between A beta 42 and LLMD would improve the understanding of the association between LLMD and AD. We reviewed 15 studies that analyzed the relationship between soluble A beta 42 and LLMD. For studies looking at plasma and/or cerebrospinal fluid (CSF) levels of A beta 42, the relationship between LLMD and soluble A beta 42 was equivocal, with some studies finding elevated A beta 42 levels associated with LLMD and others finding the opposite, decreased levels of A beta 42 associated with LLMD. It may be that there is poor reliability in the diagnosis of depression in late life, or variability in the criteria and the scales used, or subtypes of depression in late life such as early vs. late onset depression, vascular-related depression, and preclinical/comorbid depression in AD. The different correlations associated with each of these factors would be causing the inconsistent results for soluble A beta 42 levels in LLMD, but it is also possible that these patterns derive from disease stage-dependent differences in the trajectory of CSF A beta 42 during older age, or changes in neuronal activity or the sleep/wake cycle produced by LLMD that influence A beta 42 dynamics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available